Physician profile
Sean C Egan
NPI 1164588711
$1,784.41
in general payments reported to CMS, 2019-2025
20 companies · $315 in 2025
The $315 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $74.32 · 2021: $409 · 2022: $260 · 2023: $176 · 2024: $402 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $457.19 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $311.64 | 2019-2022 | |
| Boston Scientific Corporation | $152.95 | 2021-2025 | General - Erectile Dysfunction |
| Coloplast Corp | $144.11 | 2024 | |
| Gilead Sciences, INC. | $74.32 | 2020 | |
| Clarus Therapeutics INC. | $69.88 | 2021 | |
| Olympus America INC. | $66.14 | 2025 | Itind System |
| Halozyme INC | $64.31 | 2023 | |
| Abbvie INC. | $60.64 | 2024-2025 | |
| Janssen Biotech, INC. | $57.98 | 2022-2025 | Carvykti, Rybrevant, Erleada |
| Teleflex LLC | $54.46 | 2021 | |
| Azurity Pharmaceuticals, INC. | $49.24 | 2025 | Azmiro |
| Dentsply Ih Ab | $44.46 | 2024 | Lofric |
| Urogen Pharma, INC. | $34.95 | 2024 | |
| Sumitomo Pharma America, INC. | $33.27 | 2024-2025 | Gemtesa |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $27.87 | 2021 | |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Axonics, INC. | $21.07 | 2022 | |
| Telix Pharmaceuticals | $18.24 | 2024 | Illuccix |
| Pfizer INC. | $17.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Egan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.